Claiming Breach of Agreement, Rosetta Genomics Ending Licensing Deal with Avatao
June 13, 2012
Claiming Breach of Agreement, Rosetta Genomics Ending Licensing Deal with Avatao
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Rosetta Genomics Terminates Deal with Avatao
July 17, 2012 / GenomeWeb Daily News - Rosetta Genomics, Prime Health Reach Deal for Coverage of MiRview Mets2 Assay
May 20, 2013 / GenomeWeb Daily News - Rosetta, Precision Therapeutics Reach Co-marketing Deal for miRview mets2 Assay
July 24, 2012 / GenomeWeb Daily News - Rosetta Genomics Restructures, Eliminating 35 Positions
October 11, 2011 / GenomeWeb Daily News - Rosetta Genomics Granted US Patent for miRNA Used in Diagnostic Tests
May 12, 2011 / Gene Silencing News